Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, injection site genuinely matters. The three licensed sites for Mounjaro — abdomen, thigh, and upper arm — all deliver the medicine reliably, but absorption speed, injection comfort, and how much you notice side effects can all vary depending on where you inject. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber will guide your technique as part of your clinical assessment. The core rule from the NHS tirzepatide guidance is simple: rotate your sites, and keep a few centimetres away from previous injection spots so skin stays healthy over time.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The abdomen tends to give the most predictable absorption because it has a generous layer of subcutaneous fat and good blood supply. Most clinical protocols for subcutaneous GLP-1 medicines use the abdomen as the primary reference site for this reason. The outer thigh works nearly as well and is easy to reach if you inject while seated. The upper arm is convenient if someone else can administer the dose, but self-injection into this site is trickier to do cleanly, it is perfectly valid, just harder to control the angle.
What the NHS SmPC and the Mounjaro SmPC on the eMC make clear is that absorption differences between sites are modest and unlikely to change your overall results. Consistency matters more than the site you choose. Picking the same general area at the same time each week, then moving around within that area, smooths out week-to-week variability more effectively than switching sites at random.
Many people settle into a rhythm around an existing habit: injecting just before they take the pen from the fridge, at the same point in their evening routine, in the same general spot. That kind of predictable pattern is exactly what prescribers tend to recommend.
Repeatedly injecting the same small patch of skin causes lipohypertrophy, a localised build-up of fatty, fibrous tissue that feels firmer than the surrounding area. Injecting into this tissue reduces absorption unpredictably, which can blunt Mounjaro's effect in ways that look like the medicine has stopped working. It is one of the more common but correctable reasons people plateau.
Rotation means moving at least 2–3 centimetres from your last injection point, both within a chosen site and across sites over successive weeks. A loose grid-style pattern across the lower abdomen works well for most people. If you are wondering whether site choice matters because you have noticed a change in how the medicine feels, lipohypertrophy is worth checking first: run a finger across your usual area and feel for any firm patches.
Scarred tissue, stretch marks, and areas with active skin changes should be avoided entirely. The same applies to the waistband zone directly at the belt line, where friction and pressure can irritate injection sites.
Beyond the physiology, a few practical factors shift the decision. If you experience injection-site reactions (mild redness, itching, or a small raised area after injecting) the thigh is often better tolerated than the abdomen, possibly because clothing puts less pressure on it afterwards. Reactions are generally mild and settle quickly, but consistently injecting into already-irritated skin slows healing.
Temperature matters too. Mounjaro is stored refrigerated, and injecting a cold pen can increase discomfort at any site. Letting the pen sit at room temperature for a few minutes before use, as many patients find easier with the pen stored in the fridge door rather than the back shelf, often reduces the sting. For precise guidance on how long the pen can remain unrefrigerated before use, the Patient Information Leaflet is the authoritative source, Mounjaro's storage requirements are worth reviewing if you are new to the medicine.
If you are considering site choice alongside broader questions about which injection site tends to work best for different situations, our prescribers address that in detail during your consultation. The right answer depends on your body composition, skin condition, and routine, not a generic ranking.
Site rotation is a clinical topic, not just a technique preference. If you are already on Mounjaro and wondering whether where you inject is affecting how well the medicine works, it is a direct and legitimate question for your prescriber. Tell them which sites you use, whether you have noticed any firm or numb patches, and whether you have had any skin reactions.
For people earlier in the process, understanding how the Mounjaro KwikPen works including where to use it, is part of what a thorough initial consultation should cover. At nume, that consultation is reviewed the same day it is submitted by a real prescriber, not processed by software. No referral, no waiting list. If you are ready to explore whether Mounjaro is clinically suitable for you, a full overview of the medicine is a good place to start before booking.
On cost: Mounjaro is a private prescription, and prices vary between providers. A Mounjaro price comparison can help you understand what the market looks like, but for a prescription medicine, clinical oversight and genuine supply chain should be the primary consideration. When you are ready, start your free consultation with our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.